Blackberry pigment (whitlockite) gallstones in uremic patient

2013 ◽  
Vol 37 (2) ◽  
pp. e69-e72 ◽  
Author(s):  
Andrea Cariati
Keyword(s):  
Uremic Patient

Nutritional Management of the Uremic Patient

1998 ◽  
pp. 783-802
Author(s):  
August Heidland ◽  
Katarina Sébekova ◽  
Markus Teschner
Keyword(s):  
Nutritional Management ◽  
Uremic Patient

scholarly journals Dramatic Alteration of the Skull in a Uremic Patient with Leontiasis Ossea

2014 ◽  
Vol 53 (17) ◽  
pp. 1971-1976 ◽  
Author(s):  
Su-Yan Duan ◽  
Chang-Ying Xing ◽  
Guang Yang ◽  
Ning-ning Wang ◽  
Bo Zhang
Keyword(s):  
Uremic Patient

A Case Attributed to Cefazolin and a Review of the Literature

1978 ◽  
Vol 12 (5) ◽  
pp. 268-271 ◽  
Author(s):  
Marie E. Gardner ◽  
William L. Fritz ◽  
Robert N. Hyland
Keyword(s):  
Renal Failure ◽  
Serum Level ◽  
Uremic Patient ◽  
Review Of The Literature ◽  
Potential Complication ◽  
Pathophysiologic Mechanisms

Generalized convulsions developed in a uremic patient who had received massive doses of cefazolin which resulted in a measured serum level of greater than 512 mcg/ml of drug after dialysis. Pathophysiologic mechanisms which could have contributed to the symptoms are discussed. Physicians prescribing cefazolin and other cephalosporins need to be aware of this potential complication of therapy and adjust doses accordingly in renal failure.

Digoxin determination in the uremic patient: three immunoassays compared.

1985 ◽  
Vol 31 (7) ◽  
pp. 1246-1246 ◽  
Author(s):  
P R Oldfield ◽  
B E Singer ◽  
P A Toseland
Keyword(s):  
Uremic Patient

scholarly journals Nicorandil-Induced Hyperkalemia in a Uremic Patient

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Hung-Hao Lee ◽  
Po-Chao Hsu ◽  
Tsung-Hsien Lin ◽  
Wen-Ter Lai ◽  
Sheng-Hsiung Sheu
Keyword(s):  
Potassium Channel ◽  
Potassium Ions ◽  
Uremic Patient ◽  
Membrane Hyperpolarization ◽  
Voltage Gated ◽  
Antianginal Agent ◽  
Voltage Gated Calcium Channels ◽  
Detailed Evaluation ◽  
Potassium Channel Activator ◽  
Channel Activator

Nicorandil is an antianginal agent with nitrate-like and ATP-sensitive potassium channel activator properties. After activation of potassium channels, potassium ions are expelled out of the cells, which lead to membrane hyperpolarization, closure of voltage-gated calcium channels, and finally vasodilation. We present a uremic case suffering from repeated junctional bradycardia, especially before hemodialysis. After detailed evaluation, nicorandil was suspected to be the cause of hyperkalemia which induced bradycardia. This case reminds us that physicians should be aware of this potential complication in patients receiving ATP-sensitive potassium channel activator.

Sign in / Sign up

Export Citation Format

Share Document